Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Invested Capital: 2020-2024

Historic Invested Capital for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $96.7 million.

  • Oncology Institute's Invested Capital fell 4027.14% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.9 million, marking a year-over-year decrease of 4027.14%. This contributed to the annual value of $96.7 million for FY2024, which is 3276.38% down from last year.
  • Latest data reveals that Oncology Institute reported Invested Capital of $96.7 million as of FY2024, which was down 3276.38% from $143.9 million recorded in FY2023.
  • Oncology Institute's Invested Capital's 5-year high stood at $203.8 million during FY2022, with a 5-year trough of $33.5 million in FY2020.
  • Moreover, its 5-year median value for Invested Capital was $104.2 million (2021), whereas its average is $116.4 million.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 21121.04% in 2021, then tumbled by 3276.38% in 2024.
  • Over the past 5 years, Oncology Institute's Invested Capital (Annual) stood at $33.5 million in 2020, then skyrocketed by 211.21% to $104.2 million in 2021, then surged by 95.66% to $203.8 million in 2022, then fell by 29.41% to $143.9 million in 2023, then tumbled by 32.76% to $96.7 million in 2024.
  • Its last three reported values are $96.7 million in FY2024, $143.9 million for FY2023, and $203.8 million during FY2022.